Vanta Bioscience Ltd
BSE:540729

Watchlist Manager
Vanta Bioscience Ltd Logo
Vanta Bioscience Ltd
BSE:540729
Watchlist
Price: 19.5 INR Market Closed
Market Cap: ₹138.6m

Relative Value

540729 doesn't have a meaningful market cap.

The Relative Value of one VANTABIO stock under the Base Case scenario is hidden INR. Compared to the current market price of 19.5 INR, Vanta Bioscience Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VANTABIO Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

VANTABIO Competitors Multiples
Vanta Bioscience Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Vanta Bioscience Ltd
BSE:540729
138.7m INR 11.2 -3.1 -8.7 -4.8
US
PerkinElmer Inc
LSE:0KHE
1.3T USD 462.4 5 478.1 1 606.3 3 227.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
238.1B USD 5.4 36 25.5 32.9
US
Danaher Corp
NYSE:DHR
167.3B USD 6.9 47.7 25.5 38.6
KR
Samsung Biologics Co Ltd
KRX:207940
83T KRW 15 51.9 30.5 40.7
CH
Lonza Group AG
SIX:LONN
38.2B CHF 5.4 52.7 39.7 39.7
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD 2.6 31.8 15.2 22.9
CN
WuXi AppTec Co Ltd
SSE:603259
276.7B CNY 6.3 18.5 18.6 18.6
US
Agilent Technologies Inc
NYSE:A
38.4B USD 5.5 29.5 22.9 27.3
US
Mettler-Toledo International Inc
NYSE:MTD
29.1B USD 7.4 34.8 25.1 27.9
FR
Sartorius Stedim Biotech SA
PAR:DIM
20B EUR 6.8 75.9 26.8 44.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Vanta Bioscience Ltd
BSE:540729
Average EV/EBITDA: 183.6
Negative Multiple: -8.7
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 606.3
5%
321.3
US
Thermo Fisher Scientific Inc
NYSE:TMO
25.5
6%
4.2
US
Danaher Corp
NYSE:DHR
25.5
5%
5.1
KR
Samsung Biologics Co Ltd
KRX:207940
30.5
20%
1.5
CH
Lonza Group AG
SIX:LONN
39.7
18%
2.2
US
IQVIA Holdings Inc
NYSE:IQV
15.2
8%
1.9
CN
WuXi AppTec Co Ltd
SSE:603259
18.6
30%
0.6
US
Agilent Technologies Inc
NYSE:A
22.9
14%
1.6
US
Mettler-Toledo International Inc
NYSE:MTD
25.1
4%
6.3
FR
Sartorius Stedim Biotech SA
PAR:DIM
26.8
19%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Vanta Bioscience Ltd
BSE:540729
Average EV/EBIT: 352
Negative Multiple: -4.8
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
3 227.1
29%
111.3
US
Thermo Fisher Scientific Inc
NYSE:TMO
32.9
15%
2.2
US
Danaher Corp
NYSE:DHR
38.6
16%
2.4
KR
Samsung Biologics Co Ltd
KRX:207940
40.7
28%
1.5
CH
Lonza Group AG
SIX:LONN
39.7
22%
1.8
US
IQVIA Holdings Inc
NYSE:IQV
22.9
14%
1.6
CN
WuXi AppTec Co Ltd
SSE:603259
18.6
23%
0.8
US
Agilent Technologies Inc
NYSE:A
27.3
22%
1.2
US
Mettler-Toledo International Inc
NYSE:MTD
27.9
6%
4.6
FR
Sartorius Stedim Biotech SA
PAR:DIM
44.1
31%
1.4